AU2001268163A1 - Haplotypes of the ube3a gene - Google Patents
Haplotypes of the ube3a geneInfo
- Publication number
- AU2001268163A1 AU2001268163A1 AU2001268163A AU6816301A AU2001268163A1 AU 2001268163 A1 AU2001268163 A1 AU 2001268163A1 AU 2001268163 A AU2001268163 A AU 2001268163A AU 6816301 A AU6816301 A AU 6816301A AU 2001268163 A1 AU2001268163 A1 AU 2001268163A1
- Authority
- AU
- Australia
- Prior art keywords
- haplotypes
- ube3a gene
- ube3a
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20853900P | 2000-06-01 | 2000-06-01 | |
PCT/US2001/017994 WO2001092582A1 (en) | 2000-06-01 | 2001-06-01 | Haplotypes of the ube3a gene |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001268163A1 true AU2001268163A1 (en) | 2001-12-11 |
Family
ID=22774958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001268163A Abandoned AU2001268163A1 (en) | 2000-06-01 | 2001-06-01 | Haplotypes of the ube3a gene |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001268163A1 (en) |
WO (1) | WO2001092582A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004030036D1 (en) * | 2003-12-23 | 2010-12-23 | Autogenomics Inc | Multiplex analysis of nucleic acids for the determination of human papillomavirus genotypes |
US20140298494A1 (en) * | 2011-07-25 | 2014-10-02 | Beth Israel Deaconess Medical Center, Inc. | Animal model of autism |
DK3461895T3 (en) | 2012-06-25 | 2020-07-20 | Ionis Pharmaceuticals Inc | MODULATION OF UBE3A-ATS EXPRESSION |
WO2016086104A1 (en) | 2014-11-25 | 2016-06-02 | Ionis Pharmaceuticals, Inc. | Modulation of ube3a-ats expression |
WO2016179584A1 (en) | 2015-05-07 | 2016-11-10 | University Of South Florida | Modified ube3a gene for a gene therapy approach for angelman syndrome |
BR112018007633A2 (en) * | 2015-11-12 | 2018-11-06 | F. Hoffmann-La Roche Ag | paternal ube3a expression induction oligonucleotides |
JP2022525564A (en) * | 2019-03-21 | 2022-05-17 | ピーティーシー セラピューティクス, インコーポレイテッド | Vectors and Methods for Treating Angelman Syndrome |
KR20210144822A (en) | 2019-03-29 | 2021-11-30 | 아이오니스 파마수티컬즈, 인코포레이티드 | Compounds and methods for modulating UBE3A-ATS |
AU2020334924A1 (en) * | 2019-08-22 | 2022-04-07 | The Regents Of The University Of California | UBE3A for the treatment of Angelman syndrome |
-
2001
- 2001-06-01 AU AU2001268163A patent/AU2001268163A1/en not_active Abandoned
- 2001-06-01 WO PCT/US2001/017994 patent/WO2001092582A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO2001092582A1 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268163A1 (en) | Haplotypes of the ube3a gene | |
AU2002211373A1 (en) | Haplotypes of the por gene | |
AU2001276919A1 (en) | Haplotypes of the mmp13 gene | |
AU2001259595A1 (en) | Haplotypes of the crybb1 gene | |
AU2001296300A1 (en) | Haplotypes of the ccr6 gene | |
AU2001286949A1 (en) | Haplotypes of the bf gene | |
AU2001280727A1 (en) | Haplotypes of the adrb3 gene | |
AU2001253386A1 (en) | Haplotypes of the impdh2 gene | |
AU2001281123A1 (en) | Haplotypes of the isl1 gene | |
AU2001290603A1 (en) | Haplotypes of the or11a1 gene | |
AU2001253101A1 (en) | Haplotypes of the scn2b gene | |
AU2001284736A1 (en) | Haplotypes of the pla2g1b gene | |
AU2001286890A1 (en) | Haplotypes of the scya2 gene | |
AU2002236581A1 (en) | Haplotypes of the cyp3a5 gene | |
AU2001273117A1 (en) | Haplotypes of the appbp1 gene | |
AU2001274995A1 (en) | Haplotypes of the rlbp1 gene | |
AU2002227177A1 (en) | Haplotypes of the scya21 gene | |
AU2002213185A1 (en) | Haplotypes of the chrm5 gene | |
AU2001292815A1 (en) | Haplotypes of the scya8 gene | |
AU2001286644A1 (en) | Haplotypes of the gng7 gene | |
AU2002245073A1 (en) | Haplotypes of the f2rli gene | |
AU2001249650A1 (en) | Haplotypes of the chrnb3 gene | |
AU2001264967A1 (en) | Haplotypes of the gpr3 gene | |
AU2001261373A1 (en) | Haplotypes of the gpr4 gene | |
AU2001247813A1 (en) | Haplotypes of the fkbp8 gene |